Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma
ConclusionAdding CC to IMRT provided no survival benefit but increased treatment-associated toxicities in patients with intermediate-risk NPC.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | China Health | Intensity-Modulated Radiation Therapy | Nasopharyngeal Cancer | Oral Cancer | Study | Toxicology